Two Sigma Advisers’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Other funds holding PDSB
IWA
SI
Two Sigma Advisers's PDSB Position: Q1 2024 in Review
Two Sigma Advisers sold out of PDS Biotechnology (PDSB) in Q1 2024, closing a stake of 109,100 shares — an estimated $542K sold.
Two Sigma Advisers first reported a position in PDSB in Q2 2018 and held it in 14 quarters. The position peaked at $7.38M in Q4 2022. 72 funds tracked by Wall St. Rank hold PDSB as of Q1 2024.
- Two Sigma Advisers reported no remaining PDS Biotechnology position as of Q1 2024 after selling out during the quarter.
- Two Sigma Advisers sold 109,100 PDS Biotechnology shares in Q1 2024, an estimated $542K.
- Two Sigma Advisers first reported a position in PDS Biotechnology in Q2 2018 and held it in 14 quarters.
- Two Sigma Advisers's PDS Biotechnology position peaked at $7.38M in Q4 2022.
- 72 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2024.
Based on Two Sigma Advisers's 13F filing for Q1 2024, filed 15 May 2024.